KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,300 | +14.2% | 22,461 | +6.7% | 0.00% | – |
| Q2 2023 | $189,423 | +5.5% | 21,047 | -7.8% | 0.00% | – |
| Q1 2023 | $179,475 | +48.8% | 22,834 | +27.9% | 0.00% | – |
| Q4 2022 | $120,652 | +43.6% | 17,848 | +209.5% | 0.00% | – |
| Q3 2022 | $84,000 | +9.1% | 5,766 | -26.4% | 0.00% | – |
| Q2 2022 | $77,000 | -92.5% | 7,837 | -88.8% | 0.00% | – |
| Q1 2022 | $1,033,000 | +15.9% | 70,068 | +4.0% | 0.00% | – |
| Q4 2021 | $891,000 | +284.1% | 67,351 | +408.4% | 0.00% | – |
| Q3 2021 | $232,000 | -16.8% | 13,248 | +13.4% | 0.00% | – |
| Q2 2021 | $279,000 | -43.4% | 11,687 | -39.1% | 0.00% | – |
| Q1 2021 | $493,000 | +97.2% | 19,196 | +45.6% | 0.00% | – |
| Q4 2020 | $250,000 | +32.3% | 13,187 | -11.9% | 0.00% | – |
| Q3 2020 | $189,000 | -18.2% | 14,965 | -21.4% | 0.00% | – |
| Q2 2020 | $231,000 | +51.0% | 19,037 | -4.9% | 0.00% | – |
| Q1 2020 | $153,000 | +96.2% | 20,023 | +359.2% | 0.00% | – |
| Q4 2019 | $78,000 | -13.3% | 4,360 | -43.2% | 0.00% | – |
| Q3 2019 | $90,000 | -20.4% | 7,675 | +50.3% | 0.00% | – |
| Q2 2019 | $113,000 | -31.1% | 5,106 | -10.9% | 0.00% | – |
| Q1 2019 | $164,000 | +88.5% | 5,729 | +30.4% | 0.00% | – |
| Q4 2018 | $87,000 | +1640.0% | 4,394 | +1693.5% | 0.00% | – |
| Q3 2018 | $5,000 | – | 245 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
| TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
| VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
| TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
| Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
| Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
| GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
| DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
| Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |